| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |